CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $5.35M invested in Can-Fite BioPharma in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

0.04% more ownership

Funds ownership: 0.02% → 0.06% (+0.04%)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.96M
2
+$1.77M
3
+$129K
4
Morgan Stanley
Morgan Stanley
New York
+$66.6K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$15K

Top Sellers

1
-$29K
2
-$6.12K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.96M
2
$1.77M
3
$1.06M
4
$352K
5
$161K
6
$20K
7
$15K
8
$5K
9
$4.32K
10
$4K
11
$4K
12
–
13
–